509 results on '"MYSLIWIEC, MICHAL"'
Search Results
2. Single center experience of subclinical rejections and BK nephropathies by kidney allografts’ surveillance biopsies
3. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease
4. Endocan — the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease
5. Unexpected and striking effect of heparin-free dialysis on cytokine release
6. The effect of nephrectomy on Klotho, FGF-23 and bone metabolism
7. oxLDL – the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients
8. Relationship between Hydrocarbon Generation and Reservoir Development in the Carpathian Foreland (Poland)
9. YKL-40 in hemodialyzed patients with and without cardiovascular complications – The enhancement by the coexistence of the seropositivity against hepatitis C virus infection
10. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio — Are they real oxidative stress markers in dialyzed patients?
11. Mechanism of Inhibitory Effect of 3- Hydroxykynurenine on Erythropoiesis in Patients with Renal Insufficiency
12. Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
13. Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis?
14. Hyperhomocysteinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis
15. Possible Involvement of Serotonin in the Haemostatic Action of DDAVP in Patients with Uraemia
16. Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients
17. Hyperfibrinolysis, uPA/suPAR System, Kynurenines, and the Prevalence of Cardiovascular Disease in Patients With Chronic Renal Failure on Conservative Treatment
18. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease
19. Effects of enoxaparin on myeloperoxidase release during hemodialysis
20. Low concentration of heparin used for permanent catheters canal locking is effective and diminishes the risk of bleeding
21. Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism
22. Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients
23. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure
24. Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients
25. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients
26. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients
27. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients
28. Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease
29. Thyroid Function, Endothelium, and Inflammation in Hemodialyzed Patients: Possible Relations?
30. Different effect of unfractionated heparin and enoxaparin on circulating proangiogenic factors during hemodialysis: A cross-over study
31. Chronic viral hepatitis and iron affect the plasma levels of LIGHT—a new member of the TNF superfamily in uraemic haemodialyzed patients
32. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients
33. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients
34. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity
35. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients
36. Sulodexide induces hepatocyte growth factor release in humans
37. LIGHT—A new member of the TNF superfamily in the plasma, dialysate and urine of uremic patients; the impact of residual diuresis and presence of viral hepatitis
38. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease
39. Fluvastin therapy affects TAFI concentration in kidney transplant recipients
40. Renalase, Hypertension, and Kidney — The Discussion Continues
41. Inflammation but not oxidative stress is associated with β-chemokine levels and prevalence of cardiovascular disease in uraemic patients
42. Oxidative stress effects fibrinolytic system in dialysis uraemic patients
43. Carotid atherosclerosis is associated with enhanced β-chemokine levels in patients on continuous ambulatory peritoneal dialysis
44. Left ventricular morphology and function in diabetic and nondiabetic hemodialyzed patients
45. Renalase as a Possible Risk Factor of Cardiovascular Complications in Hemodialysis
46. Iron Metabolism in Hemodialyzed Patients—Still a Mystery?
47. Full-Length TFPI Release by Heparinoid Sulodexide
48. Visfatin and endothelial function in dialyzed patients
49. Effect of Sulodexide on Plasma Transforming Growth Factor-β1 in Healthy Volunteers
50. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer - evaluation of the prognostic significance of these agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.